Trial intelligence / Profile preview

Screening-detected hypothyroidism crossover trial of levothyroxine versus placebo

2005-003464-30Phase 4Completed

Sponsor
Queen Mary University of London
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Participant preference between treatment periods. Started Aug 2005; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on 2005-003464-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003464-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call